213 related articles for article (PubMed ID: 36843935)
1. Targeting acetyl-CoA carboxylase 1 for cancer therapy.
Yu Y; Nie Q; Wang Z; Di Y; Chen X; Ren K
Front Pharmacol; 2023; 14():1129010. PubMed ID: 36843935
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-CoA Carboxylases and Diseases.
Wang Y; Yu W; Li S; Guo D; He J; Wang Y
Front Oncol; 2022; 12():836058. PubMed ID: 35359351
[TBL] [Abstract][Full Text] [Related]
3. Fine-tuning acetyl-CoA carboxylase 1 activity through localization: functional genomics reveals a role for the lysine acetyltransferase NuA4 and sphingolipid metabolism in regulating Acc1 activity and localization.
Pham T; Walden E; Huard S; Pezacki J; Fullerton MD; Baetz K
Genetics; 2022 Jul; 221(4):. PubMed ID: 35608294
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic avian reovirus σA-modulated fatty acid metabolism through the PSMB6/Akt/SREBP1/acetyl-CoA carboxylase pathway to increase energy production for virus replication.
Hsu CY; Chen YH; Huang WR; Huang JW; Chen IC; Chang YK; Wang CY; Chang CD; Liao TL; Nielsen BL; Liu HJ
Vet Microbiol; 2022 Oct; 273():109545. PubMed ID: 35998542
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial β-oxidation in castration-resistant prostate cancer cells.
Liu S; Lai J; Feng Y; Zhuo Y; Zhang H; Chen Y; Li J; Mei X; Zeng Y; Su J; Deng Y; Jiang F; Yang S; Tan H; Hon CT; Wei S; Han Z; Wang F; Zhong W
J Biol Chem; 2023 Jan; 299(1):102720. PubMed ID: 36410440
[TBL] [Abstract][Full Text] [Related]
6. Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model.
Tamura YO; Sugama J; Iwasaki S; Sasaki M; Yasuno H; Aoyama K; Watanabe M; Erion DM; Yashiro H
J Pharmacol Exp Ther; 2021 Nov; 379(3):280-289. PubMed ID: 34535562
[TBL] [Abstract][Full Text] [Related]
7. Acetyl CoA carboxylase shares control of fatty acid synthesis with fatty acid synthase in bovine mammary homogenate.
Wright TC; Cant JP; Brenna JT; McBride BW
J Dairy Sci; 2006 Jul; 89(7):2552-8. PubMed ID: 16772574
[TBL] [Abstract][Full Text] [Related]
8. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
Harwood HJ; Petras SF; Shelly LD; Zaccaro LM; Perry DA; Makowski MR; Hargrove DM; Martin KA; Tracey WR; Chapman JG; Magee WP; Dalvie DK; Soliman VF; Martin WH; Mularski CJ; Eisenbeis SA
J Biol Chem; 2003 Sep; 278(39):37099-111. PubMed ID: 12842871
[TBL] [Abstract][Full Text] [Related]
9.
Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
Front Immunol; 2018; 9():495. PubMed ID: 29675017
[No Abstract] [Full Text] [Related]
10. Improving production of malonyl coenzyme A-derived metabolites by abolishing Snf1-dependent regulation of Acc1.
Shi S; Chen Y; Siewers V; Nielsen J
mBio; 2014 May; 5(3):e01130-14. PubMed ID: 24803522
[TBL] [Abstract][Full Text] [Related]
11. New experiments of biotin enzymes.
Lynen F
CRC Crit Rev Biochem; 1979 Dec; 7(2):103-19. PubMed ID: 41682
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-CoA carboxylase from yeast is an essential enzyme and is regulated by factors that control phospholipid metabolism.
Hasslacher M; Ivessa AS; Paltauf F; Kohlwein SD
J Biol Chem; 1993 May; 268(15):10946-52. PubMed ID: 8098706
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis.
Mao J; DeMayo FJ; Li H; Abu-Elheiga L; Gu Z; Shaikenov TE; Kordari P; Chirala SS; Heird WC; Wakil SJ
Proc Natl Acad Sci U S A; 2006 May; 103(22):8552-7. PubMed ID: 16717184
[TBL] [Abstract][Full Text] [Related]
14. [Activities of 3-hydroxy-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and rate of biosynthesis of mevalonic acid, squalene, sterols and fatty acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: changes induced by daily rhythm].
Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
Biokhimiia; 1981 Jan; 46(1):126-39. PubMed ID: 6113851
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-cancer activity of ND-646 and its derivatives as acetyl-CoA carboxylase 1 inhibitors.
Li EQ; Zhao W; Zhang C; Qin LZ; Liu SJ; Feng ZQ; Wen X; Chen CP
Eur J Pharm Sci; 2019 Sep; 137():105010. PubMed ID: 31325544
[TBL] [Abstract][Full Text] [Related]
16. Medium-chain fatty acids as short-term regulators of hepatic lipogenesis.
Geelen MJ
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):141-6. PubMed ID: 7915110
[TBL] [Abstract][Full Text] [Related]
17. Negative feedback regulation of fatty acid production based on a malonyl-CoA sensor-actuator.
Liu D; Xiao Y; Evans BS; Zhang F
ACS Synth Biol; 2015 Feb; 4(2):132-40. PubMed ID: 24377365
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-CoA carboxylase-a as a novel target for cancer therapy.
Wang C; Rajput S; Watabe K; Liao DF; Cao D
Front Biosci (Schol Ed); 2010 Jan; 2(2):515-26. PubMed ID: 20036965
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic phenotype of acetyl-CoA-carboxylase-defective yeast cells--viability of a BPL1-amber mutation depending on its readthrough by normal tRNA(Gln)(CAG).
Hoja U; Wellein C; Greiner E; Schweizer E
Eur J Biochem; 1998 Jun; 254(3):520-6. PubMed ID: 9688262
[TBL] [Abstract][Full Text] [Related]
20. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors.
Chen L; Duan Y; Wei H; Ning H; Bi C; Zhao Y; Qin Y; Li Y
Expert Opin Investig Drugs; 2019 Oct; 28(10):917-930. PubMed ID: 31430206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
